Russell Investments »

Atara Biotherapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Atara Biotherapeutics shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $17 2 8.50

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Eli Lilly And Company Common Stock (LLY)
Unitedhealth Group Common Stock (UNH)
Welltower Common Stock (WELL)
Prologis Common Stock (PLD)
Digital Realty Trust Common Stock (DLR)
J P Morgan Chase And Common Stock (JPM)

View all positions for Russell Investments

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Centiva Capital
Acadian Asset Management
Millennium Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Woodline Partners
BlackRock
Renaissance Technologies
Geode Capital Management

View all funds holding Atara Biotherapeutics